A monthly toric contact lens can allow digital device users to experience all-day comfort, even with more than 8 hours of wear.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Choroidal vascularity index can reveal treatment response and disease activity among patients with chronic CSCR undergoing PDT treatment.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.

A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.

People still see COVID-19 as an ongoing public health threat, even though the pandemic officially ended in 2023.

Fasting plasma glucose (FPG), age, body mass index (BMI), and male sex are all associated with development of diabetes.

Topline results were announced from a phase 2/3 trial evaluating linsitinib for the treatment of moderate to severe thyroid eye disease.

Volumetric myopia defocus dosage may be useful for predicting long-term axial growth in patients undergoing ortho-k.

Patients with higher Magnesium Deficiency Scores were associated with increased risks for both rheumatoid arthritis and osteoarthritis. Magnesium deficiency may elevate the risks for rheumatoid ...

Findings showed the difference in mean change in BCVA at week 12 between ONS-5010 and ranibizumab was -1.009 letters. Topline data were announced from a phase 3 trial demonstrating ONS-5010 ...